It sounds like the ultimate power move. , strap on your biometric tracker, take a precise cocktail of nootropics, endure a cold plunge, and spend the rest of the day optimizing every calorie and every ...

Gene editing is a numbers game. For any genetic tweaks to have notable impact, a sufficient number of targeted cells need to have the disease-causing gene deleted or replaced. Despite a growing ...

CRISPR Therapeutics AG is commercially validated with CASGEVY but remains financially unproven and operates at a loss despite strong cash reserves. Incremental buying is attractive now for patient ...

CRISPR Therapeutics has some promising and innovative pipeline candidates. The stock will soar if it can execute and deliver strong clinical and regulatory progress. CRISPR Therapeutics has lagged the ...

Casgevy is starting to build some serious sales momentum. CRISPR Therapeutics also has a deep pipeline and healthy funding. The stock requires patience, but there is a visible path to a bright future.

Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually by 2050. Now, scientists at UC San Diego have unveiled a powerful new CRISPR ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Longevity has become a $4.6 trillion conversation. But so far, much of it has been happening ...

As the $900 billion U.S. franchise industry expands in 2026, a new wave of membership-driven wellness brands are redefining how franchising scales — and who owns it. ByMeggen Harris, Contributor.

A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...

Biohackers chasing the fountain of youth are turning to an unlikely new tool: nicotine. Once demonized for its role in cigarettes, the addictive stimulant is now being recast as a cognitive enhancer ...